null CQDM funds a collaborative research project between the RI-MUHC and Divocco AI

Dr. Thomas Hemmerling leads the development of an artificial intelligence-driven technology designed to improve regional anesthesia

CQDM announced today the funding of a research study to be carried out at the Research Institute of the McGill University Health Centre (RI-MUHC) in collaboration with Divocco AI, a Montreal-based company focusing on perioperative care improvement using artificial intelligence (AI)-derived medical devices. The funding, totalling $1,057,502, was made possible by a grant of $325,327 from the Ministère de l’Économie, de l’Innovation et de l’Énergie (MEIE) via CQDM, as well as a $732,175 contribution from Divocco AI.

Congratulations to Dr. Thomas Hemmerling, scientist in the Injury Repair Recovery Program at the RI-MUHC and professor in the Department of Anesthesia at McGill University, who will work with his team from The Intelligent Technology in Anesthesia research group (ITAG), as well as Divocco AI, to optimize the use of nerve blocks for regional anesthesia.

Read the press release on CQDM website.

December 8, 2022